(19)

(11)

EP 4 798 168 A1

(12)

(43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24799208.4 (22) Date of filing: 29.10.2024

(51) International Patent Classification (IPC):  A61K 9/107(2006.01) A61K 9/16(2006.01) A61K 47/14(2017.01) A61K 9/14(2006.01) A61K 47/12(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/1075; A61K 9/141; A61K 47/12; A61K 47/14; A61K 9/1617 (86) International application number: PCT/EP2024/080621 (87) International publication number: WO 2025/093572 (08.05.2025 Gazette 2025/19)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 29.10.2023 US 202363594010 P (71) Applicant: TRX Biosciences Limited London EC4N 8AF (GB)	(72) Inventors: GOODING, Daniel London EC4N 8AF (GB) BREW, John London EC4N 8AF (GB) BANNISTER, Robin M. London EC4N 8AF (GB) (74) Representative: Schlich  9 St Catherine's Road Littlehampton West Sussex BN17 5HS West Sussex BN17 5HS (GB)